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ORIGINAL ARTICLE / ÖZGÜN ARAŞTIRMA 
Evaluation of the analytical performance of Roche immunoturbidimetric 
immunoglobulin assays and comparing to Dade Behring immunonephelometer
Roche immüntürbidimetrik immunoglobulin analizlerinin analitik performans değerlendirmesi 
ve Dade Behring immünnefelometri ile karşılaştırılması
Cevdet Züngün1, Fatma Meriç Yılmaz1,2, Bağdagül Çakır1 
ÖZET
Amaç:  Bu  çalışmanın  amacı  Roche  immuntürbidimetrik 
immunoglobulin analizlerinin analitik performanslarının de-
ğerlendirilmesi yanında bu metot ile elde edilen sonuçların 
immunnefelometrik yöntem kullanılan Dade Behring II ci-
hazı ile karşılaştırılmasıdır.
Yöntemler:  Roche  immuntürbidimetrik  yöntemin  tekrar-
lanabilirlik, alt ölçüm sınırı, linearite ve numune taşınma 
etkisi  (carry  over  efekti)  değerlendirmelerinde,  düşük  ve 
yüksek Ig konsantrasyonlarına sahip hasta örnekleri ve iç 
kalite  kontrol  materyalleri  kullanıldı.  Doğruluk  analizi  dış 
kalite kontrol sonuçları değerlendirilerek yapıldı. 451 hasta 
serumu immuntürbidimetrik metot kullanan Roche Hitachi 
Modular P Sistem ve immunnefelometrik metot kullanan 
Dade  Behring  BNII  immünnefelometride  analiz  edilerek 
metot karşılaştırması geçekleştirildi.
Bulgular:  Roche  immünoturbidimetrik  immunoglobulin 
analizlerinin  tekrarlanabilirlik  çalışmalarında  IgG  için  ke-
sinlik değeri 1.37% iken, IgA ve IgM için kesinlik değerleri 
sırasıyla 3.88% ve 5,34% olarak tespit edildi. Roche im-
münoturbidimetrik ve Dade Behring nefelometrik IgG, A ve 
M analizleri arasındaki korelasyon katsayıları ise sırasıyla 
0.967, 0.979 ve 0.939 olarak bulundu.
Sonuç: İmmünoturbidimetrik Roche Ig analizlerinde tek-
rarlanabilirlik IgA ve M için kabul edilebilir total presizyon 
limitlerinin  üzerinde  bulunurken,  IgG  için  kabul  edilebilir 
limitler dahilinde bulundu. İmmünoturbidimetrik Roche Ig 
analizleri için alt ölçüm sınırlarının üreticinin sağladığı bil-
gilerle uyum gösterdiği tespit edildi. İmmünoturbidimetrik 
Roche Ig analizlerinin referans aralıkları içerisinde lineer 
olduğu,  ancak  çok  yüksek  antikor  konsantrasyonlarında 
güvenilmez  sonuçların  oluştuğu  gözlendi.  Dade  Behring 
BNII  nefelometri  analizöründe  çalışılan  aynı  örneklerin, 
Roche türbidimetrik metotla çalışıldığında dilüsyona ihtiyaç 
duyması, Dade Behring II otoanalizörlerinin daha geniş bir 
linearite aralığına sahip olduğunu ortaya koymuştur. 
Anahtar kelimeler: Ig G, Ig A, Ig M, immünoturbidimetri, 
immünonefelometri
ABSTRACT
Objective: The aim of this study is to evaluate the analyti-
cal performance of the Roche immunoturbidimetric immu-
noglubulin assays, and also compare the results obtained 
by Roche immunoturbidimetric method to Dade Behring 
II Nephelometer.
Methods: Low and high concentration patient samples 
and internal quality control materials were used to evalu-
ate precision, limit of detection (LoD) linearity, and sample 
carry over of Roche immunoturbidimetric analyzer. Exter-
nal quality control results were used to evaluate accuracy. 
For method comparison, 451 patients serum were ana-
lyzed using Roche Hitachi Modular P System with an im-
munoturbidimetric method and Dade Behring BNII immu-
nonephelometer with an immunonephelometric method. 
Results:  In  precision  study  on  Roche  immunoturbidi-
metric immunoglobulin assays, imprecision values were 
1.37%, 3.88% and 5.34% for IgG, A and M, respectively. 
Correlation  coefficents  between  Roche  immunoturbidi-
metric analysis and Dade Behring BN II immunoneph-
elometer were 0.967, 0.979 and 0.939 for IgG, IgA and 
IgM respectively.
Conclusion: In immunoturbidimetric Roche Ig analyses 
precision for IgG was allowable according to the the de-
sirable quality specifications. However, both IgA and IgM 
had higher imprecisions than the desirable total precision. 
Immunoturbidimetric Roche Ig analyses were found lin-
ear in the reference values but unreliable results were ob-
served in the presence of excess antigen. The same sam-
ples performed on Roche analyzers needed to be diluted 
suggesting Dade Behring had wider linearity range than 
Roche immunoturbidimetric analyzer in the presence of 
excess antigen. J Clin Exp Invest 2014; 5 (3): 362-367
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INTRODUCTION
Turbidimetry and nephelometry are both based on 
the scattering of radiation by a solution containing 
dispersed  particulate  matter  [1].  The  main  techni-
cal difference in nephelometry is that the amount of 
radiation scattered by the particles is measured by 
viewing at right angles to the incident light while in 
turbidimetry the amount of radiation transmitted by 
the suspension is measured. The fraction of the scat-
tered radiation and the reasons directing the scatters 
such as the number of particles, their size and shape 
are the main factors in making the choice between 
turbidimetry and nephelometry. In the presence of 
many particles leading a large scale of scattering, 
turbidimetry  generally  yields  more  reliable  results. 
On the other hand nephelometry is preferable at low 
concentrations of analytes owing to easier measur-
ing of a small amount of scattered radiation than a 
change in density of transmitted radiation Immuno-
globulins (Ig) G, A and M are part of analytes clas-
sified as “specific proteins” that have wide ranging 
clinical  utility.  Single  radial  immunodiffusion  (RID) 
and electro-immunodiffusion which is a variation of 
RID  have  been  early  methods  of  immunoglobulin 
quantitation used in clinical settings. Ig testing per-
formed using methodology of immunonephelometry 
or immunoturbidimetry on routine clinical chemistry 
analyzers providing faster results have replaced RID 
techniques. Automation of Ig quantitation on general-
purpose clinical chemistry systems provides random 
access, rapid analysis, high volume testing, and cost 
reduction [2]. The International Federation of Clinical 
Chemistry (IFCC) and Laboratory Medicine’s Com-
mittee on Plasma Proteins has designated both im-
munonephelometry and immunoturbidimetry as ref-
erence methods for quantitation of IgG, IgA and IgM 
in serum or plasma [3].
The aim of this study is to evaluate the ana-
lytical performance of the Roche immunoturbidimet-
ric immunoglubulin G, A and M assays in terms of 
linearity in the presence of excess antigen, limit of 
detection (LoD) of the assays, sample carry over, 
precision and accuracy. Also a method comparison 
study  was  performed  employing  Dade  Behring  II 
nephelometer as the reference method for method 
validation of Roche immunoturbidimetric immuno-
globulin assays.
METHODS
1. Evaluation of Precision for Roche 
immunoturbidimetric Ig assays
The precision studies were performed according to 
Clinical and Laboratory Standarts Institute Educa-
tion Protocol 5 (CLSI EP-5A2), Evaluation of Pre-
cision  Performance  of  Quantitative  Measurement 
Methods  [4].  Within-run  imprecisions  were  deter-
mined  using  low  and  high  concentration  internal 
quality control materials. Within-run percentage co-
efficient variations (CVw %) were based on 20 rep-
licate measurements of selected samples per ana-
lytical run. Total precisions (CVa%) were obtained 
measuring  human  serum  aliquotes  in  an  internal 
protocol as 1 run per day and 10 days. 
2. Limit of detections (LoD) of assays on 
Roche immunoturbidimetric Ig assays
Twenty replicates of the lowest concentration cali-
brator material and saline were used to calculate the 
limit of blank (LoB) and LoD following CLSI EP17-A 
[5]. Standart deviations (SD) and mean values of 
saline (blank) were used to calculate LoB from the 
formula LoB = Meanblank + 1.45 SDblank. LoD was 
determined using LoB value and 1.645 fold SD of 
lowest concentration calibrator material mean value 
( LoD = LoB + 1.645.SD lowest calibrator level) [5].
3. Assessment of linearity for Roche 
immunoturbidimetric Ig assays
Linearity across the reference range values
In present study we also evaluated the linearity of 
Roche immunoturbidimetric IgG, A and M assays 
across the range of reference intervals. Six dilutions 
(6 (high): 1 (low), through 1 (high): 6 (low)) of low 
and high level commercial quality control materials 
were analyzed. Diluted samples were run in dupli-
cate in a single run on Roche Hitachi Modular P 
analyzer. 
Linearity in the presence of excess antigen
Linearity  was  evaluated  following  the  directions 
present  in  CLSI  EP6-A  [6].  Six  dilutions  derived 
from high and low concentration patient samples for 
each IgG, IgA and IgM were used to assess linearity 
in the presence of excess antigen. All three samples 
were diluted 6 (high): 1 (low), through 1 (high): 6 
(low). Diluted samples were run in duplicate in a sin-
gle run on Roche Hitachi Modular P analyzer. The 
observed results were compared to the theoretical 
(calculated) results for each dilutions. Upper limits 
of linearity for IgG, IgA and IgM were determined 
following  ±  10%  linearity  recovery  specifications 
between the equal concentration ranges of serial 
dilutions. The average concentration point that the 
diluted sample exceeded ± 10% linearity recovery 
was determined as the upper limit of linearity for re-
lated immunoglobulin. Züngün C. et al. Evaluation of the analytical performance of two methods 364
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4. Sample carry-over on Roche 
immunoturbidimetric Ig assays
Three  replicates  of  saline  measurements  (s1,  s2 
and s3) immediately after three replicates of high 
concentration  samples  of  IgG  (2403  mg/dL),  IgA 
(612 mg/dL) and IgM (416 mg/dL) assays (a1, a2 
and a3 for each analytes) were performed to evalu-
ate sample carry over. Carry over was calculated 
using the formula (s1-s3) / (a3-s3) [7,8]. 
5. Evaluation of accuracy for Roche 
immunoturbidimetric Ig assays
The retrospective results of our laboratory in RIQAS 
external quality results were observed to evaluate 
accuracy for the peer group of Roche Hitachi ana-
lyzer.
6. Subjects and ethics
451 patient specimens delivered to our laboratory 
from different clinics of our hospital for routine IgG, 
A, and M testing were used in the present study. 222 
of patients were male aged between 20-88 years 
(mean  age:  60.49  ±  14.13)  and  229  of  patients 
were female aged between 19-91 years (mean age: 
61.45 ± 14.31). A total of 113 patients (57 male; 56 
female) had a diagnosis of multiple myeloma. 93 
patients (63 male and 30 female) had renal disor-
ders as acute or chronic renal deficiency and ne-
phrotic syndrome and 245 remaining were patients 
with various diagnoses including diabetes mellitus, 
anemia, leukocyte disorders, trombocytopenia, viral 
hepatitis and different malignancies. All procedures 
in the present study were approved by our institu-
tion’s responsible committee in accordance with the 
Helsinki Declaration of 1975.
7. Specimens and analyzers for method 
comparison study
Fasting blood samples were obtained from patients 
to plain tubes. Sera were separated after centrifu-
gation at 1500 g for 10 minutes and analyzed using 
Roche Hitachi Modular P System (Roche Diagnos-
tics GmBH Mannheim, Germany) with an immuno-
turbidimetric method and Dade Behring BNII immu-
nonephelometer (Dade Behring Canada Inc.) with 
an immunonephelometric method.
8. Assessment of total error for Roche 
immunoturbidimetric Ig assays
The total error (TE) can be calculated in a number 
of ways. The most usual way is to add bias and 
precision linearly [9]. We calculated TE for the im-
munoturbidimetric method according to the formula 
below;
TE = Bias % + CV 
Absolute value of % average of Bland&Altman 
plot differences were considered to be % bias and 
and total CVs of IgG, A and M as stated in Table 1.
Table 1. Total and within-run imprecision values of IgG, 
A and M
Mean
(mg/dL)
SD
(mg/dL)
CVw%
(ww(%)
CVa
%
IgG
Low QC level 753.10 13.46 1.78
High QC level 1148.05 33.78 2.94
Human Serum 1223.90 16.80 1.37
IgA
Low QC level 143.31 4.02 2.81
High QC level 222.30 3.79 1.70
Human Serum 251.70 9.77 3.88
IgM
Low QC level 75.47 4.46 5.91
High QC level 100.47 3.33 3.23
Human Serum 113.8 6.07 5.34
Low QC: low concentration quality control material, High 
QC: high concentration quality control material, SD: stan-
dart deviation, CVw: within-run precision, CVa: total preci-
sion
9. Statistical Analysis
Method  comparison  results  were  assessed  using 
Bland&Altman difference plots analysis to calculate 
the  bias  and  limits  of  agreement.  Data  normality 
was assessed using Kolmogorov - Smirnov test. A 
Paired t - test or Wilcoxon test was used to com-
pare the mean values of methods. Values of p<0.05 
were accepted as statistically significant. The non-
parametric test of Spearman’s rank and Pearson 
correlation tests were used to evaluate correlation 
between  the  results.  MedCalc  statistical  software 
(ver.12.3.0.0.;  Belgium)  and  SPSS  13.0  for  Win-
dows software (Chicago, IL) were used to perform 
calculations.
RESULTS
1. Precision of Roche immunoturbidimetric Ig 
assays
Calculation  of  within-run  percentage  coefficient 
variations  (CVw  %)  were  based  on  20  replicate 
measurements of selected samples per analytical 
run and total CVa % (between-run) values obtained Züngün C. et al. Evaluation of the analytical performance of two methods 365
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measuring  human  serum  aliquotes  in  an  internal 
protocol as 1 run per day and 10 days. The total re-
sults of precision studies are represented in Table 1. 
2. Limit of Detections (LoD) of Assays for 
Roche immunoturbidimetric Ig assays
LoD values observed for immunoturbidimetric IgG, 
A and M on Roche Hitachi Modular P analyzer were 
30.5 mg/dL, 4.63 mg/dL and 3.38 mg/dL, respec-
tively.
3. Linearity for Roche immunoturbidimetric Ig 
assays
Across the reference range values
Six dilutions of low and high level commercial qual-
ity control materials with the concentrations of re-
lated analytes which were close to the stated lower 
and upper limits (723-1110 mg/dL for IgG, 141-218 
mg/dL and 67.7-94.1 mg/dL for IgM). Contrast to the 
presence  of  excess  antigen,  correlation  between 
measured and calculated IgG (R2 = 0.989) , IgA (R2 
= 0.987) and IgM (R2 = 0.970) was high. 
Presence of excess antigen
Six  dilutions  derived  from  high  and  low  concen-
tration patient samples for each IgG (8935 mg/dL 
- 961.4 mg/dL), IgA (7470 mg/dL - 72 mg/dL) and 
IgM (9184 mg/dL - 63.7 mg/dL) were used to assess 
linearity in the presence of excess antigen. The ob-
served  results  were  compared  to  the  theoretical 
(calculated)  results  for  each  dilutions  of  IgG,  IgA 
and IgM. Correlations between the calculated and 
measured values of IgG (R2 = 0.662), A (R2 = 0.707) 
and M (R2= 0.685) were all low. Upper linearity limits 
for IgG, IgA and IgM were determined as 3500 mg/
dL, 775 mg/dL and 1800 mg/dL, respectively.
4. Sample carry-over on Roche 
immunoturbidimetric Ig assays
The mean results of 3 replicate measurements of 
IgG, A and M assays performed using saline were 
1.6 mg/dL, 0 mg/dL and 7.1 mg/dL, respectively.
5. Accuracy of Roche immunoturbidimetric Ig 
assays
The  results  of  our  laboratory  in  RIQAS  external 
quality assessments for cycle 47 for previous nine 
months were in acceptable limits for standard de-
viation index (SDI < 2), total score (TS > 50) and % 
deviation (DEV % < defined acceptable limits) for 
our peer group of Roche Hitachi analyzer.
6. Method comparison study
IgG, A and M were measured in 451 serum sam-
ples by Roche Hitachi Modular P and Dade Behring 
BNII nephelometer. The mean ± SD value of IgG 
and mean and (min-max) values for IgA and IgM are 
summarized in Table 2. The obtained Spearman’s 
rank correlation coefficients were 0.967, 0.979 and 
0.939 for IgG, IgA and IgM, respectively.
Table 2.  Comparison  of  results  between  two  methods 
Roche Hitachi Modular P and Dade Behring BNII
n Roche Hitachi
(Turbidimetric)
Dade Behring BNII
(Nephelometric) R2
IgG (mg/dL) 451 1351.86 ±803.56 1375.95±861.53 0.967
IgA (mg/dL) 451 261 (166-367) 232 (148.5-335) 0.979
IgM (mg/dL) 451 100 (61.5-139.5) 79 (48.0- 112.5) 0.939
R2:  indicates  the  correlation  coefficients  between  the 
methods. Data represents median mean ± SD for IgG as-
says and median (min. - max.) values for IgA and M with 
95 % confidence interval.
Agreement  between  results  obtained  by  im-
munoturbidimetric and nephelometric methods are 
demonstrated in different plots using Bland&Altman. 
There was no evidence of systematic bias (found as 
0.7%) (limits of agreement, -26.0 to 27.4) for IgG 
(Figure 1). However the absolute values for system-
atic bias was 12.2% (limits of agreement, - 46.0 to 
21.7) for IgA (Figure 2) and 22.2% (limits of agree-
ment, -72.6 to 28.3) for IgM (Figure 3).
Figure 1. Bland&Altman plots of the difference between 
Ig G assays performed on Roche Hitachi Modular P and 
Dade Behring BNII nephelometer against the mean Ig G 
values of 451 patients.Züngün C. et al. Evaluation of the analytical performance of two methods 366
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Figure 2. Bland&Altman plots of the difference between 
Ig A assays performed on Roche Hitachi Modular P and 
Dade Behring BNII nephelometer against the mean Ig A 
values of 451 patients.
Figure 3. Bland&Altman plots of the difference between 
Ig M assays performed on Roche Hitachi Modular P and 
Dade Behring BNII nephelometer against the mean Ig M 
values of 451 patients.
7. Total error of Roche immunoturbidimetric 
Ig assays
As calculated using the TE formula, TEs of Roche 
Hitachi Modular P for IgG, A and M turbidimetric as-
says were 2.07%, 16.08% and 27.5%, respectively.
DISCUSSION
According to the literature we reviewed, there are 
no published articles for evaluation of the analytical 
performance of immunoglobulin assays on Roche 
Hitachi Modular P immunoturbidimetric method. 
Desirable  specifications  for  imprecision  were 
obtained by using half of the with-in biological varia-
tion values of IgG, A and M as given in http://www.
westgard.com/database1.htm.  In  precision  study 
we found total precision of IgG acceptable for the 
desirable  quality  specifications  of  total  precision 
that is equal to 2.3 % for IgG. However, both IgA 
and IgM had higher imprecisions than the desirable 
total precision which is 2.5% for IgA and 3.0 % for 
IgM. 
The judgment of acceptability depends on what 
amount of analytical error is allowable without affect-
ing or limiting the use and interpretation of individual 
test results [10]. Total error concept composed of 
random error and systematic error was also evalu-
ated for our study group data. Allowable total error 
limits were obtained from the charts summarized in 
http://www.westgard.com/database1.htm.  We  cal-
culated TE for IgG as 2.07% where the allowable 
total error for this analyte was 8.0%. TE for Roche 
Hitachi Modular P was also in acceptable limits for 
IgG as total precision was. However, Ig A with 16.08 
% and IgM with 27.54% total error percentages both 
exceeded the allowable total error limits which are 
defined as 13.4% for IgA and 16.8% for IgM.
LoD values determined for IgG, A and M were 
30.46  mg/dL,  4.63  mg/dL  and  3.38  mg/dL  verify-
ing the data stated in manufacturer’s kit inserts as 
30mg/dL, 4mg/dL and 5 mg/dL, respectively.
The equation in materials and methods section 
of this paper used for determining carry over as-
sumes that any differences between each of three 
low  concentration  samples  should  contribute  to 
only to with-in run precision if there is no carry over. 
Sample carry over coefficients (k) for IgG, IgA and 
IgM were all far below the CVs of the triple mea-
surements indicating the absence of sample carry 
over.
Our  results  in  Randox  International  Quality 
Assessment Scheme (RIQAS) external quality as-
sessments for immunoturbidimetric immunoglobulin 
analysis were in acceptable limits for our peer group 
of Roche Hitachi analyzer, however it must be con-
sidered that the consensus mean values of IgG, A 
and M were all in the reference ranges and compa-
rable to the results of immunonephelometry as the 
reference method. In order to avoid unreliable re-
sults in concentrations of immunoglobulins exceed-
ing the linearity limits, further studies are thought 
to be needed to determine the linear limits for each 
immunoglobulin method before adapting immuno-
turbidimetric analysis in a clinical laboratory.Züngün C. et al. Evaluation of the analytical performance of two methods 367
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There are different studies in the literature com-
paring immunoturbidimetric immunoglobulin assays 
against Dade Behring BN II immunonephelometer. 
Other  analyzers  such  as Abbott Architect  ci8200 
had been compared to Beckman Immage for spe-
cific protein measurements by Denham et al [1]. In 
another study, immunoturbidimetric methods on Ab-
bott Architect ci8200 were compared to Dade Beh-
ring BNII nephelometer for specific protein assays 
[11]. But as we reviewed there are no any reports 
comparing the results between immunoturbidimet-
ric Roche Hitachi Modular P immunoglobulin analy-
ses and Dade Behring BN II immunonephelometer 
Correlation coefficients between Roche immunotur-
bidimetric analysis and Dade Behring BN II immu-
nonephelometer were 0.967, 0.979 and 0.939 for 
IgG, IgA and IgM respectively for 95% confidence 
interval (Table 2). It was suggested that the high 
correlation  coefficients  were  associated  with  the 
mean values of IgG, A and M all within reference 
intervals. A few data points represented as outliers 
were excluded which will lead marked discordance 
between the methods. Thus, correlation coefficients 
(R2) might be affected due to these excluded data. 
In  conclusion,  Roche  immunoturbidimetric  Ig 
analysis were found linear in the reference values 
but unreliable results were observed in the pres-
ence of excess antigen, because of impaired linear-
ity. We found upper limits of linearity for IgG (3500 
mg/dL) and IgA (775 mg/dL) comparable to data 
presented in Roche IgG (3500mg/dL) and IgA (800 
mg/dL) manufacturer’s kit inserts. For IgM, upper 
limit of linearity was approximately 1800 mg/dL was 
higher than the upper limit of linearity data given in 
Roche IgM (650 mg/dL) kit insert. In our study, pa-
tient samples including excess antigen performed 
on  Dade  Behring  BN  II  nephelometer  could  be 
measured without dilution. The same samples per-
formed on Roche Hitachi analyzers needed to be di-
luted suggesting BN II nephelometer had wider lin-
earity range than Roche Hitachi immunoturbidimet-
ric analyzer in the presence of excess antigen. We 
worked out the problem of linearity, diluting the sam-
ples serially which were including excess amounts 
of immunoglobulins till the values decreased to the 
midpoint of the reference values and following the ± 
10 % linearity recovery specifications between the 
equal concentration ranges of serial dilutions. 
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